Elena Curakova Risteska

Dr. Elena Curakova Risteska


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2014 in Case Reports in Gastrointestinal Medicine
Verified
Journal Article
Open access
PDF file
ERElena Curakova Risteska
Elena Curakova Risteska
MGM. Genadieva-Dimitrova
M. Genadieva-Dimitrova
JMJ. Misevski
J. Misevski
VCV. Caloska-Ivanova
V. Caloska-Ivanova
VAV. Andreevski
V. Andreevski
NJN. Jankulovski
N. Jankulovski
The gastrointestinal tract is the most common extranodal site involved with lymphoma accounting for 5–20% of all cases. Lymphoma can occur at any site of the body, but diffuse and extensive involvement of the peritoneal cavity is unusual and rare. We report a case of diffuse large B-cell lymphoma in a 57-year-old female infiltrating the peritoneum and omentum and presenting with ascites and pleural effusion. The performed examinations did not discover any pathological findings affecting the digestive tract or parenchymal organs, except for diffuse thickening of the peritoneum and omentum. Peripheral, mediastinal, or retroperitoneal lymphadenopathy was not registered. The blood count revealed only elevated leukocytes and on examination there were no immature blood cells in the peripheral blood. The cytology from the ascites and pleural effusion did not detect any malignant cells. Due to the rapid disease progression the patient died after twenty-two days of admission. The diagnosis was discovered postmortem with the histological examination and immunohistochemical study of the material taken during the surgical laparoscopy performed four days before the lethal outcome. Although cytology is diagnostic in most cases, laparoscopy with peritoneal biopsy is the only procedure which can establish the definitive diagnosis of peritoneal lymphomatosis.

1 July 2023 in Prilozi
Verified
Journal Article
Open access
PDF file
ERElena Curakova Risteska
Elena Curakova Risteska
MGMagdalena Genadieva-Dimitrova
Magdalena Genadieva-Dimitrova
BTBeti Todorovska
Beti Todorovska
VMVladimir Milivojevic
Vladimir Milivojevic
IRIvan Rankovic
Ivan Rankovic
MBMaja Bojadzioska
Maja Bojadzioska
In the recent decades, endothelial dysfunction (ED) has been recognized as a significant contributing factor in the pathogenesis of many pathological conditions. In interaction with atherosclerosis, hypercholesterolemia, and hypertension, ED plays a crucial role in the pathogenesis of coronary artery disease, chronic renal disease, and microvascular complications in diabetes mellitus. Although ED plays a significant role in the pathogenesis of several pregnancy-related disorders such as preeclampsia, HELLP syndrome, fetal growth restriction, and gestational diabetes mellitus, the exact pathogenetic mechanisms are still a matter of debate. The increased prevalence of these entities in patients with preexisting vascular diseases highlights the essential pathological role of the preexisting ED in these patients. The abnormal uteroplacental circulation and the release of soluble factors from the ischemic placenta into the maternal bloodstream are the main causes of the maternal ED underlying the characteristic preeclamptic phenotype. Besides the increased risk for maternal and fetal poor outcomes, the preexisting ED also increases the risk of development of future cardiovascular diseases in these patients. This study aimed to look deeper into the role of ED in the pathogenesis of several pregnancy-related hypertensive and liver diseases. Hopefully, it could contribute to improvement of the awareness, knowledge, and management of these conditions and also to the reduction of the adverse outcomes and additional long-term cardiovascular complications.

27 April 2022 in World Journal of Hepatology
Verified
Journal Article
Open access
ERElena Curakova Risteska
Elena Curakova Risteska
MGMagdalena Genadieva-Dimitrova
Magdalena Genadieva-Dimitrova
Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators

15 August 2024 in Clinical Case Reports
Verified
Journal Article
Open access
ERElena Curakova Risteska
Elena Curakova Risteska
GKGregor Krstevski
Gregor Krstevski
MAMisel Andov
Misel Andov
AKAleksandar Kolev
Aleksandar Kolev
KBKristijan Bundovski
Kristijan Bundovski
ABAnte Bogut
Ante Bogut
Key Clinical Message: Upper gastrointestinal bleeding due to primary aortoesophageal fistula is a rare clinical condition burdened with high mortality rate. However, the outcomes are closely related to the level of clinical awareness, the complementary and multidisciplinary approach during the diagnostic workup, and the selected treatment option. We present an atypical case of an aneurysm of the thoracoabdominal aorta complicated with primary aortoesophageal fistula (AEF). A 55‐year‐old male with no previous diseases, presented with prolonged and intense back pain and upper gastrointestinal bleeding. The gastroscopy detected an unusual culprit lesion in the distal esophagus resembling an esophageal wall defect, and the computed tomography revealed an aneurysm of the thoracoabdominal aorta, remarkable surrounding hematoma, and active contrast extravasation. Despite the urgent surgical repair, a lethal outcome occurred. AEF patients require high clinical awareness and complementary multidisciplinary approach in order to provide a rapid diagnosis and optimal treatment.

14 February 2021
Verified
Book Chapter
Open access
PDF file
ERElena Curakova Risteska
Elena Curakova Risteska
Hepatic and extrahepatic factors contribute to mortality related to liver cirrhosis and therefore much research is still to be done in order to understand the condition thoroughly and to possibly intervene in the process. It is considered that the currently applied prognostic scores are not ideal mortality predictors. On the other hand, recent scientific concepts have revealed the significant contributing role of endothelial dysfunction and of systemic inflammation in the pathogenesis of portal hypertension. Consequently, these concepts are inevitably leading towards proposing and validating new prognostic indicators in cirrhotic patients. Von-Willebrand factor as an indicator of endothelial dysfunction and C-reactive protein as a surrogate marker of systemic inflammation and several other parameters and biological markers have been emerging as a relevant and potentially useful prognostic indicators. Also, the coagulopathy associated to liver disease is in close relation with these entities and still an important research topic. Despite the promising data regarding their prognostic potential, additional research is needed in order to define and validate their value more precisely in clinical and prognostic settings.

1 October 2019
Verified
Journal Article
Closed access
ERElena Curakova Risteska
Elena Curakova Risteska
MGM. Genadieva-Dimitrova
M. Genadieva-Dimitrova
VCV Caloska-Ivanova
V Caloska-Ivanova
JMJ. Misevski
J. Misevski